Cargando…
The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey
OBJECTIVE: Using oxaliplatin-based chemotherapy in the treatment of cancer patients can cause a unique form of acute and chronic peripheral neurotoxicities. This study mainly aims to assess the incidence of oxaliplatin-induced peripheral neuropathy (OXAIPN). METHODS: A cross-sectional study among 12...
Autores principales: | Ali, Nadeen T., Mohamed, Amel A., Yousef, Bashir A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325767/ https://www.ncbi.nlm.nih.gov/pubmed/32642498 http://dx.doi.org/10.4103/apjon.apjon_12_20 |
Ejemplares similares
-
Prescription patterns of antipsychotics in the management of first episode psychosis at three psychiatric hospitals in Khartoum, 2018: A descriptive cross-sectional study
por: Mohamed, Malaz M. A., et al.
Publicado: (2020) -
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015) -
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021) -
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022) -
Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity
por: Gui, Qi, et al.
Publicado: (2021)